The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.
Source: https://www.cnbc.com/2024/04/17/eli-lil ... trial.html
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
